Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
09 Jul 2013 The European Medicines Agency Extends Indications for Lapatinib Breast cancer - Anticancer agents & Biologic therapy
08 Jul 2013 Higher Risk for Development of Brain Metastases in Long-Survivors from Colorectal Cancer with Concomitant Lung Metastases and KRAS Mutations Translational research - Gastrointestinal cancers
05 Jul 2013 Influence of Prognostic Factors on Survival in Phase III, MPACT Study of Weekly Nab-Paclitaxel plus Gemcitabine in Metastatic Pancreatic Cancer Gastrointestinal cancers - Anticancer agents & Biologic therapy
04 Jul 2013 European Medicines Agency Recommends Granting Marketing Authorisation for Sipuleucel-T Genitourinary cancers - Anticancer agents & Biologic therapy
03 Jul 2013 European Medicines Agency Recommends Granting a Marketing Authorisation for Regorafenib Gastrointestinal cancers - Anticancer agents & Biologic therapy
02 Jul 2013 European Medicines Agency Recommends Granting a Marketing Authorisation for Dabrafenib Melanoma - Anticancer agents & Biologic therapy
02 Jul 2013 Pancreatic Cancer: Tackling the Tumour by Targeting its Surroundings Translational research - Gastrointestinal cancers
27 Jun 2013 Confronting the Complexity of EGFR/HER Targeted Therapies in Breast, Colorectal and Lung Cancers Personalised medicine
26 Jun 2013 A Comprehensive Genomic Mutation Profiling Analysis of Adenoid Cystic Carcinoma Pathology/Molecular biology - Translational research - Head and neck cancers
25 Jun 2013 Identifying the Drivers of Breast Cancer Breast cancer - Translational research
24 Jun 2013 A Novel Agent, Ibrutinib, Shows Potential as a Safe, Effective, Targeted Treatment Haematologic malignancies - Anticancer agents & Biologic therapy
19 Jun 2013 Just 11 Percent of Adults and 5 Percent of Children Participate in Medical Research Bioethics, legal and economic issues
17 Jun 2013 BioMarker IGF Project Aims to Identify and Validate Biomarkers for the IGF-1 Signalling Pathway in Cancer Personalised medicine - Translational research
06 Jun 2013 European Medicines Agency recommends granting a marketing authorisation for lipegfilgrastim Palliative and supportive care - Anticancer agents & Biologic therapy
05 Jun 2013 Bevacizumab: The First Agent to Remarkably Improve Survival in Recurrent Cervical Cancer Gynaecologic malignancies - Anticancer agents & Biologic therapy